Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 04 Dec 2023

PD-L1 expression complements CALGB prognostic scoring system in malignant pleural mesothelioma

in Thoracic Oncology

Alejandro Avilés-Salas
Luis Cabrera-Miranda
Norma Hernández-Pedro
Diana Sofía Vargas-Lías
Suraj Samtani
Wendy Muñoz-Montaño
Daniel Motola-Kuba
Luis Corrales-Rodríguez
Claudio Martín
Andrés F. Cardona

Frontiers in Oncology

doi 10.3389/fonc.2023.1269029

2,154 views
2 citations

Original Research

Published on 04 Dec 2023

Treatment patterns and clinical outcomes in 157 patients with extensive-stage small cell lung cancer: real-world evidence from a single-center retrospective study

in Thoracic Oncology

Yumin Zheng
Kexin Tan
Aolin Wang
Xingyu Lu
Huijing Dong
Jia Li
Huijuan Cui

Frontiers in Oncology

doi 10.3389/fonc.2023.1287628

2,737 views
1 citation

Systematic Review

Published on 01 Dec 2023

Influence of treatment-related lymphopenia on the efficacy of immune checkpoint inhibitors in lung cancer: a meta-analysis

in Thoracic Oncology

Ye Zhang
Cheng Huang
Shanqing Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1287555

1,733 views
5 citations

Case Report

Published on 27 Nov 2023

Aumolertinib: effective treatment for asymptomatic pulmonary giant cell carcinoma with EGFR L858R mutation - a case report

in Thoracic Oncology

Wenxing Yang
Ze Yang
Kaiqiang Wang
Peiquan Zhu
Jiangtao Pu

Frontiers in Oncology

doi 10.3389/fonc.2023.1279045

1,407 views
2 citations

Case Report

Published on 23 Nov 2023

Hepatoid adenocarcinoma of the lung with PD-L1 expression and the response to anti-PD-1 therapy: a case report

in Thoracic Oncology

Yan Li
Lili Liu
Dongfeng Wang
Xiaojing Tan
Yanmin Sui
Honglan Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1257931

1,290 views
2 citations

Editorial

Published on 23 Nov 2023

Editorial: Molecular genetic testing and emerging targeted therapies for non-small cell lung cancer

in Thoracic Oncology

Carlos Gil Ferreira
Marina Xavier Reis
Gilson Gabriel Viana Veloso

Frontiers in Oncology

doi 10.3389/fonc.2023.1308525

1,417 views
4 citations

Case Report

Published on 21 Nov 2023

Case Report: Genetic profiling of small intestine metastasis from poorly differentiated non-small cell lung cancer: report of 2 cases and literature review of the past 5 years

in Thoracic Oncology

Mengqin Wang
Gang Chen
Jiang Luo
Zhipeng Fan
Yuying Liu
Conghua Xie
Yan Gong

Frontiers in Oncology

doi 10.3389/fonc.2023.1265749

2,048 views
5 citations

Case Report

Published on 16 Nov 2023

Case Report: Case series: association between blood concentration and side effects of sotorasib

in Thoracic Oncology

Ryota Shigaki
Ryohei Yoshida
Akari Yagita
Kazunori Nagasue
Taeka Naraoka
Kiichi Nitanai
Hiraku Yanada
Toshiyuki Tenma
Ryotaro Kida
Yasuhiro Umekage

Frontiers in Oncology

doi 10.3389/fonc.2023.1269991

1,992 views
1 citation

Original Research

Published on 07 Nov 2023

Use of comprehensive genomic profiling for biomarker discovery for the management of non-small cell lung cancer brain metastases

in Thoracic Oncology

Mohammed Abdulhaleem
John C. Hunting
Yuezhu Wang
Margaret R. Smith
Ralph D’ jr. Agostino
Thomas Lycan
Michael K. Farris
James Ververs
Hui-Wen Lo
Kounosuke Watabe

Frontiers in Oncology

doi 10.3389/fonc.2023.1214126

2,132 views
2 citations

Correction

Published on 07 Nov 2023

Corrigendum: Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

in Thoracic Oncology

Yaxin Chen
Lei Xia
Yuxuan Peng
Gang Wang
Liyun Bi
Xue Xiao
Cui Li
Weimin Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1309950

796 views

Original Research

Published on 07 Nov 2023

Efficacy and safety of immune checkpoint inhibitors plus recombinant human endostatin therapy as second-line treatment in advanced non-small-cell lung cancer with negative driver gene: a pilot study

in Thoracic Oncology

Bo Yang
Yuzhi Li
Jie Deng
Hui Yang
Xiang Sun

Frontiers in Oncology

doi 10.3389/fonc.2023.1210267

1,306 views
2 citations

Brief Research Report

Published on 07 Nov 2023

Analysis of predictive factors of unforeseen nodal metastases in resected clinical stage I NSCLC

in Thoracic Oncology

Filippo Tommaso Gallina
Daniele Marinelli
Riccardo Tajè
Daniele Forcella
Gabriele Alessandrini
Fabiana Letizia Cecere
Francesca Fusco
Paolo Visca
Isabella Sperduti
Vincenzo Ambrogi

Frontiers in Oncology

doi 10.3389/fonc.2023.1229939

1,151 views
5 citations

Case Report

Published on 01 Nov 2023

Two case reports: EML4-ALK rearrangement large cell neuroendocrine carcinoma and literature review

in Thoracic Oncology

Qin Chen
Jingjing Zhang
Xuan Wang
Wenkang Zong
Leina Sun
Jianwen Qin
Yan Yin

Frontiers in Oncology

doi 10.3389/fonc.2023.1227980

2,478 views
6 citations

Original Research

Published on 01 Nov 2023

Relationship between driver gene mutations and clinical pathological characteristics in older lung adenocarcinoma

in Thoracic Oncology

Xia Liu
Guopeng Jiang
Xuefei Sun
Guangfeng Su
Xuan Zhang
Dan Shen
Na Yan

Frontiers in Oncology

doi 10.3389/fonc.2023.1275575

1,813 views
1 citation

Editorial

Published on 01 Nov 2023

Editorial: Primary and acquired resistance in lung cancer

in Thoracic Oncology

Rossella Bruno
Michele Simbolo
Iacopo Petrini

Frontiers in Oncology

doi 10.3389/fonc.2023.1310331

1,021 views

Review

Published on 31 Oct 2023

Segmentectomy for patients with early-stage pure-solid non-small cell lung cancer

in Thoracic Oncology

Atsushi Kamigaichi
Akira Hamada
Yasuhiro Tsutani

Frontiers in Oncology

doi 10.3389/fonc.2023.1287088

2,839 views
3 citations